Lv4
550 积分 2023-09-27 加入
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
19小时前
待确认
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
19小时前
待确认
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
19小时前
待确认
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
19小时前
待确认
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
19小时前
待确认
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
19小时前
待确认
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
19小时前
待确认
Integrating multi-modal imaging in radiation treatments for glioblastoma
19小时前
待确认
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
19小时前
待确认
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
19小时前
待确认
皖公网安备34019202002308
